# Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery

> **NCT02797119** · PHASE4 · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 225 (actual)

## Conditions studied

- Pregnancy Complications
- Hemorrhage

## Interventions

- **DRUG:** tranexamic acid 1 g (TA1)
- **DRUG:** tranexamic acid 0.5 g (TA1/2)
- **DRUG:** Saline Solution (TA0)

## Key facts

- **NCT ID:** NCT02797119
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-15
- **Primary completion:** 2021-04-15
- **Final completion:** 2021-04-15
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02797119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02797119, "Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02797119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*